The Indiana Clinical and Translational Sciences Institute (CTSI) is a statewide partnership among Indiana University, Purdue University and the University of Notre Dame – all working together to improve health in Indiana through research. The Indiana CTSI has been continuously funded since 2008 by multi-million-dollar grants from the National Institutes of Health’s National Center for Advancing Translational Sciences and is administratively managed by Indiana University through the IU School of Medicine.
Indiana CTSI Leadership
Co-Directors
Carmel Egan, PhD
Chief Operating Officer
George Wodicka, PhD
Deputy Director
Purdue University campus
Melanie DeFord, MS
Deputy Director
Notre Dame campus
Jeff Zaleski, PhD
Deputy Director
IU Bloomington campus
Scott Denne, MD
Deputy Director
IUPUI campus
Explore CTSI
Executive Strategy Team
The Indiana CTSI’s executive strategy team includes Sharon Moe, MD, Sarah Wiehe, MD, Carmel Egan, PhD, Scott Denne, MD, Tom Hurley, PhD, Peter Embi, MD, Aaron Carroll, MD, director of career development, education and research training programs at the Indiana CTSI; Rob Dimmitt, MBA, senior director of research administration and finance at the Indiana CTSI and IU School of Medicine; Christine Drury, associate director of research communications at the Indiana CTSI and IU School of Medicine; Joe Hunt, MPH, director of tracking and evaluation at the Indiana CTSI; Patricia McGuire, the Indiana CTSI’s education program manager; and Karin Davis, administrative director for the Indiana CTSI and IU School of Medicine Research Affairs.
University Leadership
Michael A. McRobbie
President
Indiana University
Mitch Daniels
President
Purdue University
Rev. John Jenkins
President
University of Notre Dame
Jay L. Hess
VP, Clinical Affairs
Indiana University
Fred H. Cate
VP, Research
Indiana University
Theresa Mayer
VP, Research
Purdue University
Robert J. Bernhard
VP, Research
University of Notre Dame
Additional Leadership
The Indiana CTSI is also guided by multiple advisory boards made up of scientific, business and community leaders and experts from across the state and the nation, including the National Center for Advancing Translational Sciences and its Clinical and Translational Science Awards (CTSA) Program.
EXTERNAL ADVISORY BOARD:
SCIENTIFIC ADVISORY BOARD:
INTERNAL ADVISORY BOARD:
David L. Johnson (Chair)
President and Chief Executive Officer
BioCrossroads
Steve Dubinett (Chair)
University of California, Los Angeles
Jay L. Hess
Dean of Indiana University School of Medicine
Andrew Dahlem
Vice President and COO Emeritus
Lilly Research Laboratories
Sergio Aguilar-Gaxiola
University of California, Davis
Fred H. Cate (Co-chair)
Indiana University
Jamie Dananberg
Chief Medical Officer
Unity Biotechnology
Robert Dittus
Vanderbilt University
Theresa Mayer (Co-chair)
Purdue University
Dan Evans
CEO Emeritus
Indiana University Health
Cynthia Morris
Oregon Health & Science University
Robert J. Bernhard (Co-chair)
University of Notre Dame
Bruce Gingles
Vice President
Cook Medical
Philip Payne
Washington University in St. Louis
Harry L. Gonso
Partner
Ice Miller LLP
Harry Selker
Tufts University
Jay McGill
COO
Indiana Biosciences Research Institute
Maureen Smith
University of Wisconsin
Dennis Murphy
President
Indiana University Health
Anantha Shekhar, MD, PhD
Founding Director Emeritus
N. Clay Robbins
Chairman, President and CEO
Lilly Endowment Inc.
